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ABSTRACT
Research suggests that elevated serum concentrations of 25-hydroxyvitamin D (25OHD)
are associated with slowing the development of many age-related chronic diseases. Recent
reports also show a positive relationship between 25OHD and muscle synthesis, strength, power
and decreased body fat in elderly individuals. However, these findings have not been
consistently reported in younger, healthy populations. PURPOSE: To investigate the
relationship between 25OHD levels, body composition, measures of aerobic fitness and muscular
strength and power in a young, physically active population. METHODS: Thirty-nine active
subjects (20 males, 19 females; 23 ± 0.7 years old) reported to the lab six times for testing.
Blood was drawn and 25OHD concentrations were determined using an enzyme-linked
immunosorbent assay (ELISA). Primary outcomes included: body composition (dual-energy xray absorptiometry, DXA); resting metabolic rate; maximal oxygen uptake (VO2max); power
output (Wingate); and strength (eight repetition maximum of bench press, upright row and leg
extension and flexion). Primary analysis included all participants, and sub-group analyses on
those individuals considered to have sub-optimal serum 25OHD (< 35 ng/mL); LOW (n = 20,
25.97 ± 1.97 ng/mL) and adequate levels of 25OHD (< 35 ng/mL) HIGH (n =19, 44.15 ± 2.17
ng/mL). RESULTS: Half of the subjects (n = 20) exhibited less than optimal 25OHD status,
due in part to lack of dietary intake. HIGH males had significantly higher VO2max values when
compared to LOW males (p < 0.01). CONCLUSION: A high percentage of college-aged male
and female individuals may not be consuming enough vitamin D and aerobic fitness may also be
linked to vitamin D status.
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CHAPTER 1 – INTRODUCTION
Vitamin D has garnered a significant amount of attention for its potential to improve
overall health and quality of life in humans. Low vitamin D status has been linked to obesity,
cardiovascular disease, type 2 diabetes, cancer and other diseases common in our society today.
However, more research is needed in order to fully understand the benefits of improving vitamin
D status and its cellular mechanisms of action.
One of the most applicable newly discovered benefits of vitamin D supplementation is its
role in muscle protein synthesis (1). Type I muscle fibers, known also as slow-twitch fibers,
have increased oxidative capacity and low glycolytic activity and are resistant to fatigue (2).
Type IIa fibers have both high oxidative and glycolytic activity, while type IIb fibers have high
glycolytic and low oxidative capacity and wear out quickly (2). Different muscles have varying
quantities of fiber types based on the type of training and genetics. For example, those who run
marathons have more type I fiber content overall, while weight-lifters have more type II fibers
(2). Originally, studies involving vitamin D and muscle growth and composition were conducted
in elderly populations (3, 4). Muscle biopsies of elderly patients with vitamin D deficiency
indicated atrophy of type II muscle fibers, which are those recruited first to help prevent falls (5).
Current research found that supplementation with vitamin D increased functional muscle tissue
in elderly patients (4). Specifically, improved lower extremity function, as assessed by 8 foot
walk tests and sit-to-stand tests, has been associated with higher 25-hydroxyvitamin D (25OHD)
levels in both active and inactive subjects over the age of 60 (4). Supplementation studies
examining the changes in muscle fiber morphology are few in number, but several have shown
an improvement in overall muscle composition. Sorensen, et al. showed that 3-6 months of
supplementation with calcium and vitamin D (in the form of 25OHD), led to an increase in
cross-sectional area of type IIa fibers (6). However, this study provided 25OHD
1

supplementation combined with calcium, and did not primarily focus on muscle morphology.
More recently, a significant increase in the number and diameter of type II fibers, along with a
concurrent increase in strength were observed after several years of supplementation in elderly
subjects (7). The most important finding in these studies was that the improvement in muscle
composition translated into an increase in functional capabilities such as strength, fall prevention
and ability to perform activities of daily living (8).
Not only does vitamin D supplementation have the potential to increase muscle protein
synthesis, but there may be concomitant reductions in adiposity as well (9). A cell culture
project determined that incubation of 3T3-L1 preadipocytes with 1,25(OH)2D prevented
differentiation into adipocytes in a dose-dependent manner (10). A complete understanding of
the role of vitamin D in adipocyte regulation has no defined direction even though multiple
possible routes show a potential understanding of the decrease in adiposity. While the
mechanisms have yet to be completely elucidated, it is apparent that improved vitamin D status
is correlated with a more favorable body composition (11).
With the increased interest in non-osseous functions of vitamin D, many researchers have
become concerned with the vitamin D status of athletes (12). Since the discovery of the
physiological changes that take place in the elderly after increasing circulating levels of 25OHD,
research has been done investigating the benefits of increasing the status in these physically
active individuals. While no conclusive results have been reported concerning the changes in
body composition or muscle physiology in a younger, physically active population, one major
determination has become apparent: a significant number of athletes – regardless of sport or
season – have insufficient or deficient vitamin D levels (12). Therefore, it is important to
investigate both the incidence of insufficiency of vitamin D in a healthy, physically active
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population, as well as the potential relationships between serum 25OHD and measures of fitness
and athletic performance.
In summary, longitudinal studies indicate that an increase in muscle tissue is
accompanied by a decrease in fat mass, and vitamin D status is one of the most robust predictors
of muscle mass decrease with aging (13). These findings lead us to ask whether similar results
will be observed in the general population. Additionally it is also important to address whether
improvements in vitamin D status result in an increase in muscle tissue and if these
improvements translate to improvement in cardiovascular and muscular performance (14).
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CHAPTER 2 – REVIEW OF LITERATURE
Sources of Vitamin D in the Diet
The majority of the world’s population has low levels of vitamin D, with estimates
reaching as high as 59 percent worldwide. Additionally, it has been estimated that over 60
percent of Americans may also be deficient in vitamin D (16, 17). This phenomenon may be due
to misinformation about the sources and conversion of vitamin D into a physiologically relevant
form. For example, some nutritionists and educators believe that sufficient amounts are ingested
in a normal healthy diet (1), while others disagree (15).
Vitamin D is readily available in the American diet, albeit not in large quantities. It is
unlikely that the prevalence of vitamin D deficiency and insufficiency would be seen at the
astronomical rates observed today if it were a standard part of a normal diet. Vitamin D is even
less likely to be found in diets in developing countries due to the reduced access to foods
naturally containing vitamin D, as well as lack of regulation regarding the fortification of foods
with vitamin D that are present in developed countries (16). Vitamin D content is highest in fatty
fish and liver, particularly cod liver (16). In the United States, most cereals, grains, orange juice
and dairy products are fortified with vitamin D, in amounts required by the Food and Drug
Administration (16). Even with adequate intake through the diet, most individuals have
insufficient vitamin D levels in the body (17). Up until late 2010, the Institute of Medicine
(IOM) Dietary Reference Intakes indicated that the Recommended Dietary Allowance (RDA) of
vitamin D should be 400 IU per day for healthy adults, with higher values for elderly and youth.
These values were regarded by nutritionists, researchers, and physicians as severely insufficient
(16). The IOM recommendation release in 2010 increased the RDA to 600 IU per day for
individuals between the ages of one and 71 years old, although this value is still widely debated
in the research community as inadequate. As a result, there is an increased likelihood for
4

individuals on a fortified diet to have low levels of vitamin D and recommendations can be made
as to increasing status applicable to everyone (18).
Vitamin D Synthesis
Vitamin D synthesis takes place in several different steps. A precursor compound known
as 7-dehydrocholesterol (7DHC), stored in the skin, is converted to previtamin D3 when photons
from UVB light come in contact with a particle of 7DHC (17). Optimal wavelengths for this
conversion are less than 315 nm (17). However, these wavelengths typically do not make it
through the ozone layer to come in contact with the surface of the earth (17). Different
wavelengths of light cause different isomers from 7DHC and limits how much previtamin D3 is
formed (17). Current estimates range from 12-15% of 7DHC is actually converted to previtamin
D3, which ultimately determines the amount of vitamin D that is synthesized (17).
Once previtamin D3 is made, it is further converted to vitamin D3 with heat (17). The
first two conversion steps happen together, since heat accompanies UV radiation. Vitamin D3 is
mobilized by binding to the D binding protein (DBP) and enters circulation. Upon reaching the
liver, vitamin D3 is converted to its active form of 25-hydroxyvitamin D (25OHD)(17). 25hydroxyvitamin D enters circulation and is converted to 1,25-dihydroxyvitamin D (1,25(OH)2D)
in the kidneys (19). It is 1,25(OH)2D that is the metabolically active form of vitamin D (17).
Because of the time course in vitamin D synthesis and metabolism, serum concentration of
25OHD is widely preferred as the standard for determining vitamin D status, when compared to
serum 1,25(OH)2D levels (19).
Vitamin D, Muscle In Elderly/Diseased vs. Athletic Populations
Even though the benefits of increased strength with vitamin D supplementation were not
a direct measure in initial studies, more recent research in elderly populations confirms that
vitamin D supplementation may lead to increased muscle strength (1), or an increase in the force
5

produced by the muscle (20). Other results have shown that increased levels of 25OHD are
positively correlated fat free mass (9), including muscle, bone, tissue, and cellular contents (21).
While results show that there is an increase in muscle tissue, as determined by DXA and biopsies
and enzymatic activity of tissue samples, it is important to note that this increase is not of clinical
significance if it is not accompanied by an improvement in strength. In fact, current studies
indicate that supplementation with vitamin D, along with strength training activities, in elderly
subjects not only leads to an increase in muscle tissue but an increase in strength as well (22).
It is well established that vitamin D plays an integral role in improving bone density and
calcium absorption (23). Research began by investigating the role of vitamin D and calcium
supplementation in elderly subjects to prevent osteomalacia, the softening of bone tissue due to
lack of vitamin D and subsequent absorption of calcium (24). Because of the increased calcium
absorption in bones, and with the aid of vitamin D, bone density increased in these patients and
osteomalacia was reduced (25). Further investigation indicated that myopathy was significantly
correlated to the prevalence of osteomalacia and decreased bone density; furthermore,
supplementation with vitamin D seemed to benefit those suffering from osteomalacia not only by
increasing bone density but by increasing muscle strength as well (6).
Vitamin D research focusing on changes in muscle mass first began when low levels of
serum 25OHD were correlated with myopathy (26). The onset of sarcopenia and loss of muscle
mass and strength is inevitable for every person, regardless of training state or physical ability.
Sarcopenia is characterized by the loss of type II muscle fibers, those that are predominately
active in strength generation (27). While many exercise rehabilitation programs focus on
resistance training for elderly individuals, the new muscle fibers that develop from this type of
training are type I fibers, which are more oxidative in nature (27). Many studies investigating
increased muscle synthesis, both as an increase in fiber number or an increase in size of existing
6

fibers, and strength in those suffering from sarcopenia note that building muscle strength is
important in elderly populations to decrease falls risks and maintain functional ability (28).
Resistance training is the preferred method of training for these individuals for two reasons: first,
the exercise directly stimulates the target of interest in skeletal muscle instead of a systemic
effect that would be characteristic of aerobic activities; secondly, because elderly individuals in
this situation are already prone to falling because of decreased strength, resistance training types
of activities can be carried out in a more controlled environment in order to decrease this risk
(22). The problem with resistance training activities is that while the muscle is being
resynthesized, it is not being replaced by a metabolic or functional equivalent in terms of fiber
types. For example, one intervention study saw increases in both type I and type II fiber crosssectional area after 15 and 30 weeks of training, but the increases in type I fibers were significant
at both time points. There was no increase in type II fiber cross-sectional area at 15 weeks, and
the increase seen at 30 weeks was vastly lower than the increase seen in type I fibers even though
it was considered statistically significant (29). Vitamin D supplementation is believed to bring a
potential solution to this problem. Several studies have indicated that vitamin D
supplementation, in conjunction with resistance training activities, increases muscle strength by
increasing the number of type II fibers (30).
The advantages of vitamin D supplementation should not be limited to the clinical
setting. While studies dating back to the 1940s have correlated vitamin D levels with increases
in strength performance in athletes (1), this interest has not been maintained until recently.
Currently, only a few studies have investigated the role of vitamin D in athletes and the
implications on performance. Research involving vitamin D supplementation has revealed the
importance of maintaining bone density, increased muscle synthesis, and its role in increasing
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immune function in athletes (31), but most have only speculated that increasing vitamin D status
in these individuals could increase performance and never explicitly explored this hypothesis.
While all of these benefits stand to increase athletic performance in trained individuals,
no specific correlations between these phenomena have been drawn to the physiological
responses that occur during exercise. A review of the literature indicates a two-fold importance
of sufficient levels of vitamin D in athletes: first, that deficiency can impede and limit
performance, and second, that increasing vitamin D levels in non-deficient athletes may improve
athletic performance (32). Some of the first studies investigating the effects of vitamin D and
athletic performance were carried out in Germany in the 1950s, when it was determined that
athletes with increased UV exposure time routinely had increased performance results. It has
also been determined recently that athletes who train indoors and during the winter are at
increased risk for deficient levels and decreased performance (32). One such study showed that
German gymnasts had significantly lower serum 25OHD levels, and 37% of participants’ levels
were in the range for osteomalacia and 45% presenting with symptoms of hypocalcemia. While
these levels were not correlated directly with a decrease in performance, the risk associated with
low levels of calcium, such as softened bone tissue and grand mal seizures (as observed in the
study) certainly leads to unsafe conditions for athletic performance (32). Although there are very
few recent, published studies that have investigated the role of vitamin D status and athletic
performance, an investigation revealed a direct positive correlation, in females ages 12 to 14
years, between serum 25OHD levels and muscle power and force using a series of leg strength
and jumping tests (33). In conclusion, athletes engaging in both aerobic and resistance types of
activities may be at risk for vitamin D deficiency-related performance implications, which are
magnified if they train or perform during winter months when natural UV levels are decreased.
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The benefits of vitamin D are well established for elderly populations (4). To date, there
has been much speculation about the performance-enhancing potential of vitamin D
supplementation in athletes (12); however, no consistent link has been made between these two
very polar populations. As a result, it is possible for clinically healthy individuals engaging in
recreational activities to benefit from an improvement in vitamin D status.
Known Molecular Mechanisms of Vitamin D
Because calcium absorption in bone is so tightly regulated by the amount of vitamin D in
the body, athletes should be careful to take in the appropriate amount of vitamin D to lower the
risk of fractures, which could impede on performance and training (31). The molecular
mechanism between 25OHD and increased cell synthesis, especially in the muscles, seems to
indicate that the active form 1,25(OH)2D binds to the vitamin D nuclear receptor. This complex
interacts with the retinoic x-receptor (RXR), which binds to vitamin D response elements
(VDRE), which activate gene sequences that regulate cell growth. This process is hypothesized
to regulated protein synthesis in muscle cells, but is not completely understood at this point (31).
Aside from its role in cell proliferation in the immune system, vitamin D has also been tied to the
secretion of antimicrobial peptides from cells of the immune system such as monocytes and
macrophages, which act by degrading the membrane of pathogenic substances (31). Vitamin D
is also hypothesized to help regulate the release of both proinflammatory and anti-inflammatory
cytokines, which are released during exercise, although this mechanism is not known at this
point (31).
Vitamin D Status and Fat Mass
Multiple studies have linked vitamin D status, quantified by both 25OHD and
1,25(OH)2D levels, to body mass. Most studies have indicated that higher 25OHD status is
correlated with lower body mass, although this relationship is not robust and some researchers
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debate on whether 25OHD or 1,25(OH)2D is the best marker of vitamin D status (19). The
consensus in the current literature seems to indicate that 25OHD is the best predictor of overall
vitamin D status, with a majority of the articles noting a stronger negative relationship between
body fat and 25OHD than with 1,25(OH)2D because of its regulation of PTH. However, it is
important to note that Lagunova, et al, indicated that both 25OHD and 1,25(OH)2D were
predictors of body mass index (BMI), fat mass, and percent adiposity (34).
Exploring the relationship between vitamin D status and body composition also has other
challenges. Because vitamin D is a fat-soluble vitamin, it is possible that those with increased
adiposity would have increased stores of vitamin D. However, this does not appear to be true.
In fact, obese individuals are one of the most at-risk populations for hypovitaminosis D, or
deficiency of vitamin D, and the associated symptoms and health risks (35). This observation is
due to the bioavailability of circulating 25OHD and the nature of vitamin D metabolism. One
study proved this phenomenon quite well, by supplementing both obese and non-obese subjects
with identical oral doses of vitamin D3 and exposing them to identical amounts of UVB light 24
hours after ingestion. The study hypothesis assumed that the obese subjects would have
increased serum levels of 25OHD due to the increased fat stores for vitamin D, as well as larger
body surface area able to absorb the UV light. The results showed the opposite. The obese
subjects had significantly lower vitamin D levels despite equal levels of 7DHC, UV exposure
time, and ingested vitamin D when compared to non-obese counterparts (36). The article
summarized, “obesity did not affect the capacity of the skin to produce vitamin D3, but may have
altered the release of vitamin D3 from the skin into the circulation” (36). A review of the
literature concurs with this notion, noting that the increased adiposity between the subcutaneous
stores of vitamin D and the circulatory system limit the available amount of 25OHD for use by
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the body, and increased in storage sites for vitamin D leading to a preference for storage rather
than circulation (34).
Although increased obesity is correlated with decreased serum 25OHD levels, there is
also significant speculation that supplementation with vitamin D could lead to an increased rate
of lipolysis (37). While the mechanism has not been completely identified at this point, one
popular belief involves the role of 1,25(OH)2D and the control of the calcium adipocyte
signaling pathway. It was previously believed that 1,25(OH)2D was responsible for increasing
calcium levels in adipocytes, causing an increase in lipogenesis and a decrease in lipolysis (38).
This tends to support the notion that increased vitamin D levels would increase adiposity, which
is not the current belief as 25OHD has been correlated with an increase in lean body mass (39).
Summary and Specific Aims
Though the relationships between vitamin D, body composition and athletic performance
have been established independently in populations of various ages (9, 21, 40), a comprehensive
study examining all of these factors together has yet to be completed in a young population.
Vitamin D also provides gains in two significant areas – clinical importance and health benefits
(41), as well as performance gains (12, 31) – that serve two very contrasting populations of
individuals. Accordingly, it the specific aim of this study to investigate the relationship between
25OHD levels, body composition and resting metabolic rate, measures of aerobic fitness, and
muscular power and strength in a young, physically active population. It is hypothesized that
many of the subjects will have low levels of 25OHD, and that there will be a positive
relationship between 25OHD and measures of aerobic fitness and strength, as well as an inverse
relationship between 25OHD and overall adiposity.
In conclusion, vitamin D is already known to be one of the most necessary supplements
for optimal health in all individuals (42). It is exciting to investigate new benefits of a
11

supplement that is already known to support necessary physiological processes, especially
knowing that most people are clinically deficient, including a large number of physically active
individuals. A positive relationship among muscle strength, mass and serum 25OHD is
somewhat substantiated by the literature (39), indicating potential benefits for athletes by
improving vitamin D levels.
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CHAPTER 3 – METHODS
Study Subjects
Forty subjects (n = 20 males, n = 20 females; ages 18-40 years) were recruited to
participate in the study. To be eligible for the study, participants were required to be physically
active in moderate to vigorous intensity activities for at least 3 days per week and have had
maintained a consistent body weight for three months prior to the study. Subjects had no history
of supplementing with vitamin D outside of what is included in a daily multivitamin (400 IU).
This project was approved by the Louisiana State University Institutional Review Board.
Study Design
Subjects reported to the lab six times. On the first day, all subjects signed an informed
consent document, completed physical activity and health assessment questionnaires and height
and weight were recorded. Subjects then completed tests to determine resting metabolic rate,
plasma vitamin D status, body composition, maximal cardiorespiratory fitness (VO2max) and
anaerobic power, strength and flexibility over the course of five additional visits that took place
over a 14-day period. At least 72 hours of rest were included between the anaerobic power,
VO2max and strength tests to allow for adequate recovery. Resting metabolic rate and blood
collection took place on days 5 to 7 of the menstrual cycle for females, as these measurements
can be influenced by hormone cycles.
Blood Collection and Analysis
During the assessment period, subjects reported to the lab for a single blood draw. They
were asked to refrain from strenuous exercise for 24 hours and fasted for 12 hours prior to
collection. A registered nurse collected 20 mL blood samples in vacutainers containing no
additive in the exercise biochemistry lab at Louisiana State University. Samples were allowed to
chill for at least one hour at 8-10°C, after which they were centrifuged at 10°C (10 minutes, 1000
13

rcf) and plasma aspirated, aliquoted and stored at -80°C until analysis. Vitamin D (25OHD)
status was determined using ELISA (Alpco Diagnostics, Salem, NH) with a BioTek microplate
reader (BioTek Instruments, Model MQX200, Winooski, Vt., USA).
Sun Exposure and Dietary Intake
A week before blood collection, subjects were issued two surveys that accounted for their
overall endogenous vitamin D production and exogenous dietary intake, which were returned at
the time of the blood collection. The first questionnaire was a sun exposure survey to quantify
the amount of time spent outdoors and in sunlight, since endogenous vitamin D is produced by
exposure to ultraviolet light. This method, set forth by Hanwell et al., combines the time spent
outdoors or in exposure to ultraviolet light into a numerical scale (43). The second questionnaire
was a seven day dietary log that was analyzed for dietary 25OHD content using the USDA
database (44).
Resting Metabolic Rate
Resting metabolic rate (RMR, kcal/day) was assessed via analysis of oxygen
consumption using a metabolic cart (Moxus Metabolic Systems, Pittsburgh, PA). Subjects
arrived at the lab after a 12-hour fast and having refrained from strenuous exercise for 24 hours.
Subjects were asked to lie in a supine position in a thermoneutral environment while data were
collected. The procedure continued until 10 minutes of steady state data was collected, defined
as ± 5% of the respiratory exchange ratio (45). RMR was calculated via the modified Weir
equation (46).
Body Composition – Dual-energy X-ray Absorptiometry (DXA)
Whole-body DXA scans were performed by a trained technician using a General Electric
Lunar iDXA (General Electric; Milwaukee, WI) and analyzed using enCORE software version
13.40. The subject first changed into a hospital gown and removed all metal objects from his or
14

her body. The subject was centered on the surface of the machine and secured. The subject was
instructed to lie completely motionless for the duration of the scan, which lasted
approximately10 minutes.
Cardiorespiratory Fitness Testing
VO2max was analyzed using a modified Bruce Protocol (47). Participants were asked to
refrain from alcohol consumption and vigorous exercise for 24 hours prior to testing. This
protocol required participants to walk or run on a treadmill while the speed and incline was
progressively increased until the subject reached fatigue. Exhaled gases were analyzed during
the testing period using a metabolic cart (Moxus Metabolic Systems, Pittsburgh, PA).
Anaerobic Power Measurements
Anaerobic power was measured on a cycle ergometer (Monark Ergomedic, Vansbro,
Sweden) using the Wingate testing protocol (48). The protocol included a self-selected warm-up
period during which the participants pedaled at a relaxed frequency against little or no resistance.
The testing period required the subjects to pedal against a given resistance, calculated based on
the body weight of the subject, for 30 seconds. This period was followed by a cool-down period
that lasted as long as was deemed necessary. Revolutions per 5 second intervals were counted
and applied to the Wingate equations (48).
Strength, Power and Flexibility Testing
Strength measurements were assessed by eight repetition maximums (8RM) for several
lifts, including upright bench press, bicep curl, tricep pushdown, leg curl, leg extension and
upright row. For assessment of power, subjects were asked to perform vertical and horizontal
jumps, with allowed countermovement before each jump. The best of three jumps was recorded
and used for data analysis. Vertical jump height was determined as the difference between the
height of outstretched hand at rest and the highest point the subject reached during the jump;
15

horizontal jump distance was determined by initial landing spot of the subjects’ heel on a marked
tape measure (49). Subjects’ flexibility was assessed by a sit-and-reach test (47).
Statistical Analysis
Data were analyzed using SPSS (Version 19, IBM, Armonk, NY). Descriptive statistics,
including mean and standard error (SE), were calculated for all outcome variables. A one-way,
four-level ANOVA was used to compare the subjects by gender and vitamin D status, either
above HIGH (>35 ng/mL) or below LOW (<35 ng/mL) the normal value for physically active
individuals (50). Student’s t-tests with a Bonferroni multiple comparison correction were used
post hoc. Pearson stepwise correlation analysis was used to determine relationships between all
measurements. Significance was set at p < 0.05. All values presented are mean ± SE.
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CHAPTER 4 – RESULTS
Subjects were between the ages of 20 and 38 years old and mean anthropometric
measurements are shown in Table 1. Forty subjects were recruited into the study. One female
was excluded from all analyses due to failure to complete testing. One male subject was
excluded from 25OHD serum analysis, as his value was considered a statistical outlier. Overall,
males had significantly higher dietary intake of vitamin D; however, there were no other
significant differences in descriptive measures aside from those expected based on variation of
body size and composition between genders (Table 1).
Vitamin D Status: Measures of Intake and Serum Content
Twenty subjects (9 females, 11 males) presented with serum 25OHD levels lower than 35
ng/mL, which is considered to be below normal in young, physically active individuals (50)
(Table 2). While the recommended daily intake of vitamin D is 600 IU (51), or 4200 IU per
week, only one subject in the study met this criterion. However, this subject’s serum 25OHD
still fell below the normal 25OHD level. The mean dietary vitamin D intake for participants was
just above 1000 IU per week, and these values did not correlate with serum levels (Figure 1).
Intake was significantly higher in males than in females (p = 0.002); however, there was no
significant difference in intake between the HIGH and LOW vitamin D groups (p = 0.93) nor
was there a relationship between vitamin D intake and serum 25OHD content (r = 0.003).
Sun Exposure
Using the charting procedure for sun exposure, scores ranged from 11 to 52. In the study
in which the survey measurement was proposed, the scores ranged from 0 to 41 (43). In
addition, there were no significant differences in sun exposure between men and women, or the
HIGH and LOW vitamin D groups (p = 0.66 and p = 0.81, respectively) (Table 2). There were
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no significant correlations in the complete data set, nor were there any correlations when divided
by gender or between the high and low 25OHD groups.
Body Composition and Resting Metabolic Rate
Aside from the expected differences in percent body fat between genders (P ≤ 0.001),
there were no other significant differences in percent body fat between groups (Table 1)(52).
There was a non-significant negative trend between vitamin D status and BMI (r = -0.31, p =
0.19). This relationship was also observed in body composition in males, showing decreased
adiposity with increased serum 25OHD (r = -0.38, p = 0.20). As expected, there was a significant
difference between RMR in men and women (P ≤ 0.001) (Table 2) but no significant difference
in resting metabolic rate between the high vitamin D group and the low vitamin D group (p =
0.94) was observed (Table 2)(53). Of the subjects with normal serum 25OHD levels, there was a
positive but non-significant correlation between resting metabolic rate and vitamin D status
(males n = 9, r = 0.26 and females, r = 0.41).
Performance Measurements
There was a statistically significant difference in VO2max between males in the low and
high groups (p ≤ 0.01), where males with serum vitamin D above the recommended levels for
physically active adults had roughly a 20% higher VO2max compared to those who fell below the
normal standard (Figure 1). This relationship was not observed in females, and there were no
other statistically significant differences in VO2max among any other groups (data not shown).
Anaerobic power (P ≤ 0.001) was significantly higher in males than females; however,
there were no significant differences in anaerobic power based on 25OHD status (p = 0.76 for
females and p = 0.34 for males) (Table 2). The lack of significance was maintained when
comparing absolute measurements or watts per body weight (kg) between LOW and HIGH
25OHD groups. As expected, males had significantly higher 8RMs in all lifts compared to
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females (P ≤ 0.001), as would be predicted (Table 2). However, there were no significant
differences between LOW and HIGH groups in any of the 8RM or flexibility measurements
(Table 2).
Correlational Analysis
Correlations were performed between 25OHD concentrations and all outcome variables
for the entire group of subjects, by gender, and by LOW and HIGH groups. No statistically
significant relationships were discovered.
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CHAPTER 5 – DISCUSSION
Based on the known and purported benefits of vitamin D, it is recommended that
physically active individuals maintain a higher vitamin D status to achieve optimal health and
performance benefits (12, 31). In this study, we also show that males who had serum 25OHD
levels above the recommended limit of 35 ng/mL had significantly higher cardiorespiratory
fitness levels when compared to males below this value. These findings are in agreement with
the results of several studies investigating the relationships among serum 25OHD,
cardiorespiratory fitness and several markers of mortality in middle-aged men and women (54,
55). These markers included several indices of obesity, changes in insulin resistance and glucose
metabolism, as well as decreases in inflammation and triglyceride content (56, 57). While the
evidence is conclusive that physical activity can induce all of these changes alone (58), it is
possible that increasing 25OHD may also induce these beneficial effects may help clinical
populations as well (57).
In this study, there were no significant relationships between strength or power output
and serum 25OHD, nor were there observed relationships between 25OHD and flexibility
measures. It has been shown that increasing serum 25OHD status in elderly populations results
in improvements in muscle mass and strength, and that low levels of 25OHD accurately predict
the acceleration in age-related loss of muscle mass (59, 60), which was not observed in the
current study. This finding may be a function of regular exercise modality. For example, males
were more inclined to engage in a structured routine with strict running distances and weight
lifting protocols while females were more likely to engage in a variety of running distances and
events or other aerobic group physical activity classes. This gender-based variation in training
regimen could potentially influence the development of muscle strength and power differently in
each group, which would cause the observed differences between males and females in strength
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and power. There were no significant differences in flexibility when associated with 25OHD
content. There are no studies in young, healthy populations investigating this relationship. Only
a few results in elderly populations show improvements in flexibility, which is due to the
changes in muscle tissue that occur with increases in 25OHD content (61).
Low levels of 25OHD are associated with high levels of body fat (9, 13). In this study,
there was a trend (p = 0.20) for a negative correlation between 25OHD and body fat percentage
in males. Additionally, there was no relationship between 25OHD and RMR and a consensus on
this relationship has not yet emerged in the literature.
Half of the healthy, physically active participants in this study presented with insufficient
or deficient levels of serum 25OHD. Clinical studies have defined deficiency as serum levels
below 10 ng/mL and insufficiency as levels between 10 and 30 ng/mL (62); however, depending
on the research environment, these reference values may fall between 15 and 35 ng/mL.
Because vitamin D studies have been conducted in a wide variety of populations, it cannot be
assumed that the same reference values apply to all individuals (63). We considered 35 ng/mL
as the normal reference value for subjects in this study because this cutoff has been used as the
reference value in a previous study with physically active individuals (32).
Studies have shown that it is difficult to achieve adequate vitamin D status using dietary
measures alone, especially when considered independent of supplementation with multivitamins
(42). In the United States, many foods are required by the Food and Drug Administration to be
fortified with vitamin D, including but not limited to: orange juice, dairy products and cereals
(63). While the fortification of these foods helps to increase vitamin D intake, they cannot be
considered a means for obtaining sufficient vitamin D (42). As a result, it is not surprising that
the dietary intake of vitamin D was extremely low in the young adults enrolled in this study. The
Institute of Medicine’s recommendation for vitamin D is 600 IU per day, and only one of the 39
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subjects in the current study met this requirement with an average daily intake of 700 IU (4,644
IU per week). This is a common trend and several recently published studies have reported
similar results in young, physically active individuals (50, 64).
Vitamin D levels (25OHD) are not only associated with dietary intake, but are also
related to UV exposure (16). Data were collected during the summer and early fall in the
southeastern United States where the number of days with adequate UV exposure from sunlight
is estimated at 218 per year. Current recommendations suggest that ten to fifteen minutes in
sunlight will produce a large amount of vitamin D, but this conversion is affected by a number of
different factors, including ethnicity, adiposity, age, geographical location, as well as behaviors
such as sunscreen use or wearing protective clothing (17, 65). In this study, sun exposure was
evaluated by a survey that allowed for direct combination of time spent in the sun as well as
overall exposure (43). We used this particular survey because many individuals in the current
study enjoy recreational activities outdoors, but did so under different conditions including time
of day or wearing various different types of clothing, making analysis of time under UV
exposure difficult. The scores obtained in the present study varied significantly as both a
function of time spent outdoors and the amount of skin exposed to sun. We found no correlation
between sun exposure or dietary intake and serum 25OHD levels. Surprisingly, we also found
no significant relationship between length of sun exposure and serum 25OHD, despite that fact
that most subjects reported infrequent sunscreen use, which maximized the potential for
endogenous vitamin D production. These results are confirmed in studies investigating the
vitamin D status of different populations in the United States (66, 67). Previous reports and the
present results indicate that individuals with significant sun exposure may still be at risk for
vitamin D deficiency.
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One of the biggest challenges in vitamin D research is the understanding of optimal levels
for different populations. Because the benefits of increasing serum 25OHD in athletes are not
completely elucidated to date, current research is beginning to determine the concentration at
which optimal health and athletic performance occurs in physically active individuals. Studies in
adolescent dancers note that non-specific musculoskeletal pain occurred with serum
concentrations as low as 20 ng/mL (68), with a decrease in athletic performance observed in a
population where mean serum 25OHD concentration was 12 ng/mL (33). It is also important to
note that optimal concentrations for populations with chronic illness are thought to be 25 ng/mL,
Accordingly, the estimate of “normal” serum 25OHD concentration (> 35 ng/mL) used in the
current study is a conservative for young, healthy, and physically individuals.
Our current study includes several limitations. First, subjects were mostly Caucasian (n =
36) with several Hispanics (n = 3) but included no African Americans. The observed levels of
insufficiency would have potentially been greater if more minorities had been recruited, as they
are at a higher risk for insufficiency or deficiency because increased melanin plays a role in
blocking the production and circulation of 25OHD (18). It is crucial to point out that our data
were analyzed using the USDA Nutrient Database for vitamin D content (44). While the
amounts listed in the USDA nutrient database include amounts of both D2 and D3, D3 is
regarded to be much more biologically active in humans (19). Therefore, the dietary analysis
included the highest possible value because it considers both forms. It should be noted that
dietary intake was significantly higher in males than in females (n = 20 males, n = 19 females).
This difference in dietary intake may be due to the fact that males tend to eat more on a daily
basis (69).
In conclusion, this study showed a positive relationship between aerobic fitness and
25OHD status in physically active males. A secondary finding was that vitamin D intake was
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lower than that which is currently recommended, and a large percentage of young, healthy and
physically active individuals had low serum levels of 25OHD. Finally, sun exposure and dietary
intake did not appear to influence 25OHD status.
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CHAPTER 6 – CONCLUSION
Results of this study are promising. A significant percent of a young, active population
presented with low levels of an important nutrient, therefore it is important to increase awareness
of the importance of including vitamin D in an overall healthy diet.. It is documented in studies
using subjects between ages ranging from adolescence to the community-dwelling elderly that
insufficient levels of 25OHD are associated with symptoms such as muscle soreness and
myopathy, even significant muscle weakness (5, 33). In children and the elderly, the benefits of
vitamin D are even more important, as bone growth and maintenance are tightly correlated with
levels of 25OHD (70). Since vitamin D is essential for bone health, as well as potentially
increasing athletic performance and altering body composition, it is important for young
individuals and athletes to appreciate its nutritive value (31).
Because there was a significant difference between males above and below the normal
serum 25OHD levels and the resulting levels of aerobic fitness, further research in the area of
supplementation and resulting athletic performance is warranted. There is very little
understanding about the direction of this relationship at this time. Some of the most recent
studies showed a positive relationship between cardiorespiratory fitness, as measured by VO2max
treadmill testing, and serum 25OHD levels (54, 55). These results are noteworthy, as the
relationship was observed in both healthy adult men and women, and was conducted using
several thousand subjects. The major disadvantage to these studies were the confounding factors
of adiposity, as there was a negative relationship observed between both 25OHD and body fat, as
well as cardiorespiratory fitness and obesity. While the former would suggest that vitamin D
status could positively influence body composition, the latter clouds the understanding of this
relationship. Many factors influence this relationship. Individuals who are more aerobically fit
tend to spend more time outdoors and consistently have diets higher in nutritious foods, most
25

definitely those that have increased vitamin D content (54). The converse relationship is also
true: those who are less fit tend to spend more time indoors and or have a diet high in processed
foods, lacking basic nutrients. Therefore, the directionality of the results observed in the
mentioned studies cannot be determined. Further work in understanding this relationship should
be conducted using a longitudinal training study, in which subjects are supplementing and
participating in a concurrent athletic training program. Resulting changes in fitness and body
composition could be compared to subjects who are given a placebo but still participating in
physical activity. In fact, this is the next step in the research plan, which began with the present
study.
Future Directions
Improvements in body composition and fitness levels are understood on many
physiological levels, but the resulting reduction in chronic levels of inflammation is perhaps the
most positive systemic change. It is understood that an increase in adiposity results in an
increase in low-grade inflammation (71). The effects of this rise in inflammation include
impaired glucose and lipid metabolism, increased insulin resistance, or vascular destruction,
which can lead to a cardiovascular event (71). However, all of these adverse effects can be
overcome in part with exercise training (72). While the concentration of inflammatory cytokines
increases acutely with exercise, chronic training leads to an increased ability to attenuate overall
inflammation by both a decrease in proinflammatory cytokines and increase in anti-inflammatory
cytokines (72). One of the secondary investigations concerning 25OHD is its role in improving
immune function (31, 64). New studies using cell culture models have indicated that 25OHD
directly inhibits the production of inflammatory cytokines IL-6 and TNF-α (73). Further
analysis indicated that this inhibition was due to binding of 25OHD to DNA, causing activation
of a gene that produces MKP-1 (73). MKP-1 interferes directly with the cellular pathway
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leading to the production of IL-6 and TNF-α (73). These results are novel and directly
applicable to clinical populations, indicating the importance of maintaining high 25OHD levels
in those suffering from obesity, type 2 diabetes, or other chronic conditions. A major topic of
interest would be the changes in inflammation that occur in the presence of increased 25OHD
concentrations in those who are physically active. This topic is of considerable interest to those
who conducted the present study and is a potential future step in their line of research.
In summary, increasing vitamin D levels has the potential to increase muscle mass and
decrease adiposity, which can potentially regulate systemic inflammation. Future research
should focus on understanding these and other physiological changes that are caused by vitamin
D. Additionally, because of the large percentage of individuals with insufficient levels of
25OHD, other investigations should focus on ways to effectively measure vitamin D status and
methods to increase functional levels in the body.
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APPENDIX 1
Table 1. Demographic and Anthropometric Measures
Gender

25OHD Status

Overall

Male

Female

Low

High

Number of Participants

39

20

19

20

19

Males (n)

20

11

9

Females (n)

19

9

10

22.75 ± 0.5

23.79 ± 1.2

Age
Height (cm)

23.26 ± 0.7

23.75 ± 1.1

22.74 ± 0.7

167.77 ± 1.9 174.37 ± 2.1 160.82 ± 2.3 169.29 ± 2.5 166.17 ± 2.9

Weight (kg)

68.85 ± 2.1

77.29 ± 2.4

59.79 ± 1.8

71.96 ± 3.1

65.40 ± 2.6

% Body Fat

24.19 ± 1.3

18.65 ± 1.5

30.02 ± 1.0

24.66 ± 1.7

23.69 ± 2.0

BMI

24.34 ± 0.6

25.45 ± 0.8

23.17 ± 0.7

24.99 ± 0.9

23.65 ± 0.7

Data are presented as means ± SE. BMI, body mass index; RMR, resting metabolic rate; 25OHD, 25-hydroxyvitamin D.
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Table 2. Performance Measures Outcomes
Gender

25OHD Status

Overall

Male

Female

Low

High

40

20

19

20

19

Males (n)

11

9

Females (n)

9

10

1438.32 ± 71.7

1432.28 ± 54.4

Number of Participants

RMR (kcal/day)

1435.38 ± 44.8

25OHD (ng/mL)

34.83 ± 1.9

Dietary Intake (IU/week) 1117.16 ± 169.2

1593.78 ± 53.7
33.02 ± 2.1
1601.90 ± 273.6†

1268.64 ± 49.6
36.73 ± 3.2

25.97 ± 1.2

44.15 ± 2.2*

606.90 ± 112.4 1131.55 ± 254.1 1102.00 ± 228.6

28.82 ± 1.8

29.60 ± 2.9

30.02 ± 1.0

28.40 ± 2.7

29.26 ± 2.3

634.45 ± 28.2

753.43 ± 31.5†

509.21 ± 25.3

662.41 ± 40.5

605.02 ± 39.1

Bench Press (kg)

68.28 ± 5.1

93.18 ± 5.3†

42.06 ± 2.6

73.44 ± 7.9

62.84 ± 6.4

Leg Curl (kg)

41.04 ± 2.4

51.98 ± 2.5†

29.51 ± 1.9

42.56 ± 3.7

39.43 ± 3.0

Leg Extension (kg)

55.76 ± 3.8

72.87 ± 4.1†

37.75 ± 2.7

58.11 ± 5.5

53.29 ± 5.2

Upright Row (kg)

54.01 ± 3.3

69.92 ± 3.2†

37.28 ± 2.1

56.52 ± 5.0

51.37 ± 4.2

Bicep Curl (kg)

27.24 ± 2.5

38.36 ± 2.6†

15.53 ± 1.9

29.40 ± 3.9

24.97 ± 3.0

Sun Exposure (score)
Anaerobic Power (watts)
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Table 2 – continued
Tricep Pushdown (kg)

62.40 ± 4.4

81.95 ± 4.8†

41.82 ± 3.5

65.60 ± 6.8

59.02 ± 5.6

Vertical Jump (cm)

47.28 ± 1.7

54.36 ± 2.1†

39.84 ± 1.2

48.13 ± 2.3

46.39 ± 2.6

166.30 ± 4.0 195.58 ± 7.6

191.30 ± 8.3

Horizontal Jump (cm)
Sit and Reach (cm)

193.50 ± 5.6 219.33 ± 5.9†
11.20 ± 2.0

6.35 ± 3.0†

16.31 ± 2.2

7.75 ± 3.0

14.84 ± 2.6

Data are presented as means ± SE. * Indicates significant difference between high and low status (p < 0.05); † Indicates significant
difference between males and females (p < 0.05).
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Table 3. Data by 25OHD Status and Gender
Females

Males

LOW

HIGH

LOW

HIGH

9

10

11

9

23.56 ± 1.0

22.00 ± 0.8

22.09 ± 0.5

25.70 ± 2.3

Height (cm)

162.00 ± 2.4†

159.77 ± 3.8†

175.26 ± 3.0

173.28 ± 3.0

Weight (kg)

61.34 ± 3.6†

58.29 ± 1.4†

80.54 ± 3.0

73.18 ± 3.76

% BF

29.81 ± 1.2†

30.20 ± 1.5

20.45 ± 2.3

16.46 ± 1.9

BMI

23.27 ± 1.0

23.08 ± 1.0†

26.40 ± 1.2

24.30 ± .89

RMR (kcal/day)

1266.00 ± 96.2†

1271.01 ± 44.0†

1579.32 ± 85.4

1611.46 ± 63.4

25OHD (ng/mL)

26.04 ± 1.9†

Number of Participants
Age

Dietary Intake (IU/week)

686.00 ± 202.8†

46.34 ± 3.8*†

25.92 ± 1.6

41.71 ± 1.6*

535.7 ± 117.9† 1181.30 ± 287.3 1731.22 ± 369.8

Sun Exposure (score)

29.33 ± 3.6†

26.8 ± 2.3†

27.64 ± 4.0

32.00 ± 4.2

VO2max (mL/kg/min)

45.98 ± 1.7†

45.02 ± 2.4†

49.66 ± 1.96

59.21 ± 2.9*

517.35 ± 38.1†

501.88 ± 35.4†

781.09 ± 39.6

719.62 ± 50.9

43.34 ± 5.2†

40.82 ± 1.8†

97.94 ± 7.9

87.19 ± 6.8

Anaerobic Power (watts)
Bench Press (kg)
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Table 3 – continued
Leg Curl (kg)

28.98 ± 3.4†

29.94 ± 2.1†

53.61 ± 3.7

49.90 ± 3.2

Leg Extension (kg)

39.31 ± 5.5†

36.29 ± 1.9†

73.40 ± 5.8

72.07 ± 6.1

Upright Row (kg)

38.81 ± 4.1†

35.83 ± 1.6†

70.93 ± 5.3

68.54 ± 3.2

Bicep Curl (kg)

16.38 ± 3.9†

14.74 ± 1.4†

40.00 ± 4.1

36.29 ± 3.2

Tricep Pushdown (kg)

44.86 ± 7.4†

39.01 ± 1.21†

82.47 ± 7.6

81.14 ± 5.6

Vertical Jump (cm)

39.79 ± 1.5†

39.88 ± 1.9†

54.96 ± 2.4

53.62 ± 3.8

169.05 ± 4.8†

163.83 ± 6.4†

217.29 ± 9.0

221.83 ± 7.5

11.85 ± 3.8†

20.32 ± 1.8†

4.49 ± 4.4

8.75 ± 4.0

Horizontal Jump (cm)
Sit and Reach (cm)

Data are presented as means ± SE. * Indicates significant difference between comparison groups of the same gender (p < 0.05).
Indicates significant difference between females and both HIGH and LOW males (p < 0.05).
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†

Figure 1.
Data represent maximal cardiorespiratory fitness (VO2max ml/kg/min) expressed as mean (SE) for males and females above (HIGH) or
below (LOW) a normal standard level of serum 25OHD (35 ng/mL). * Indicates that HIGH male subjects are significantly higher than
their LOW counterparts.
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Figure 2.
Weekly dietary intake of vitamin D among subjects (n = 38, outlier excluded) are presented as international units per week. Solid line
is simple regression line.
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APPENDIX 2
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45

46

Sun Exposure Log
ID:_________________

Dates: From _________ to _________

Time

Exposure

Monday
Sunday
Saturday
Friday
Thursday
Wednesday
Tuesday

Time

Exposure

< 5 min/day = 0 points

Face and hands only = 1 point

5-30 min = 1 point

Face, hands, arms = 2 points

> 30 min = 2 points

Face, hands, arms, legs = 3 points
Bathing suit = 4 points

Hanwell et al, 2010
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Louisiana State University Institutional Review Board Approval
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Pennington Biomedical Research Center Institutional Review Board Approval
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